These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8159589)

  • 21. [The Alagille syndrome in an adult].
    Schulte-Bockholt A; Gebel M; Wittekind C; Burdelski M; Schmidt FW
    Dtsch Med Wochenschr; 1990 Aug; 115(34):1276-9. PubMed ID: 2390942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biliary physiology and disease: reflections of a physician-scientist.
    Paumgartner G
    Hepatology; 2010 Apr; 51(4):1095-106. PubMed ID: 20373364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The biochemical and histopathological effects of ursodeoxycholic acid and metronidazole on total parenteral nutrition-associated hepatic dysfunction: an experimental study.
    Günsar C; Melek M; Karaca I; Sencan A; Mir E; Ortaç R; Canan O
    Hepatogastroenterology; 2002; 49(44):497-500. PubMed ID: 11995481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cholestasis: drug therapy].
    Leuschner U
    Praxis (Bern 1994); 1998 Nov; 87(46):1532-6. PubMed ID: 9857764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
    Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy.
    Kondrackiene J; Beuers U; Kupcinskas L
    Gastroenterology; 2005 Sep; 129(3):894-901. PubMed ID: 16143129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis.
    Beuers U
    Nat Clin Pract Gastroenterol Hepatol; 2006 Jun; 3(6):318-28. PubMed ID: 16741551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ursodeoxycholic acid treatment in intrahepatic cholestasis of pregnancy. A case report].
    Lengyel G; Fehér R; Gardó S; Fehér J
    Orv Hetil; 2002 Dec; 143(52):2885-8. PubMed ID: 12638316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cholestatic liver diseases].
    Reichel C; Meier-Abt PJ
    Ther Umsch; 1997 Nov; 54(11):639-44. PubMed ID: 9454366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
    Babatin MA; Sanai FM; Swain MG
    Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial external biliary diversion in children with progressive familial intrahepatic cholestasis and Alagille disease.
    Yang H; Porte RJ; Verkade HJ; De Langen ZJ; Hulscher JB
    J Pediatr Gastroenterol Nutr; 2009 Aug; 49(2):216-21. PubMed ID: 19561545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endoscopic retrograde cholangiopancreatography study in Alagille's syndrome: first report.
    Morelli A; Pelli MA; Vedovelli A; Narducci F; Solinas A; De Benedictis FM
    Am J Gastroenterol; 1983 Apr; 78(4):241-4. PubMed ID: 6837550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipoprotein (a) serum levels in chronic cholestatic liver disease during treatment with ursodeoxycholic acid.
    Beuers U
    Arch Intern Med; 1991 Jun; 151(6):1239-40. PubMed ID: 2043035
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of ursodeoxycholic acid on intrahepatic cholestasis in rats.
    Li L; Xu X; Lu F; Zhao N
    Chin Med J (Engl); 2003 Jul; 116(7):1099-103. PubMed ID: 12890392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrahepatic cholestasis of pregnancy.
    den Dulk M; Valentijn RM; Welten CA; Beyer GP
    Neth J Med; 2002 Oct; 60(9):366-9. PubMed ID: 12572710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ursodeoxycholic acid: an alternative in the treatment of chronic cholestasis].
    Parés A; Rodés J
    Gastroenterol Hepatol; 1996 Feb; 19(2):58-67. PubMed ID: 8616682
    [No Abstract]   [Full Text] [Related]  

  • 37. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
    Linares Rodríguez A
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
    [No Abstract]   [Full Text] [Related]  

  • 38. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited.
    Paumgartner G; Beuers U
    Hepatology; 2002 Sep; 36(3):525-31. PubMed ID: 12198643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Severe protracted cholestasis after general anesthesia in a patient with Alagille syndrome].
    Müller C; Jelinek T; Endres S; Loeschke K
    Z Gastroenterol; 1996 Dec; 34(12):809-12. PubMed ID: 9082660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of severe cholestasis in neonatal Dubin-Johnson syndrome with ursodeoxycholic acid.
    Regev RH; Stolar O; Raz A; Dolfin T
    J Perinat Med; 2002; 30(2):185-7. PubMed ID: 12012642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.